Serum chemokines in patients with psoriatic arthritis treated with cyclosporin A

Journal of Rheumatology

Volumn 25, Issue 2, 1998, Pages 320-325

  Macchioni, Pierluigi ^a,e   Boiardi, Luigi ^a   Meliconi, Riccardo ^b   Pulsatelli, Lia ^c   Maldini, Mario Casadei ^c,d   Ruggeri, Romina ^c   Facchini, Andrea ^b,c   Salvarani, Carlo ^a  

^a Servizio di Reumatologica

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Laboratorio di Immunologia e Genetica   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Chemokines; Cyclosporin A; Psoriatic arthritis

Indexed keywords

CHEMOKINE; CYCLOSPORIN A; DICLOFENAC; GENE PRODUCT; GROWTH FACTOR; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISONE; RANTES;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; DISEASE ACTIVITY; DRUG RESPONSE; FEMALE; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS;

ADULT; AGED; ARTHRITIS, PSORIATIC; CHEMOKINE CCL2; CHEMOKINES; CYCLOSPORINE; FEMALE; HUMANS; INTERLEUKIN-8; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MIDDLE AGED; RANTES; TIME FACTORS;

EID: 0031935776     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Baker B, Fry L. The immunology of psoriasis. Br J Dermatol 1992;126:1-9.
2. Griffiths CEM. Cutaneous leukocyte trafficking and psoriasis. Arch Dermatol 1994;130:494-9.
3. Wakita H, Takigawa M. E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques. Arch Dermatol 1994;130:457-63.
4. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nikoloff BJ. The cytokine network in lesional and lesion-free psoriatic skin is characterised by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993;101:701-5.
5. Schlaak JF, Buslau M, Jochum W. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994;102:145-9.
6. Mozzanica N, Cattaneo A, Trabattoni D, et al. Production of type-1 and type-2 cytokines by peripheral blood mononuclear cells of psoriatic patients. Immunology 1995;86:422-6.
7. Baggiolini M, Dewald B, Moser B. Interleukin 8 and related chemotactic cytokines CXC and CC chemokines. Adv Immunol 1994;55:97-179.
8. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking and inflammation. Curr Opin Immunol 1994;6:865-73.
9. Taub DD, Oppenheim JJ. Chemokines, inflammation and the immune system. Ther Immunol 1994;1:229-34.
10. Paludan K, Thestrup Pedersen K. Use of polymerase chain reaction in quantification of IL-8 mRNA in minute epidermal samples. J Invest Dermatol 1992;99:830-5.
11. Barker JN, Jones ML, Swenson CL, et al. Monocyte chemotactic and activating factor production by keratinocytes in response to interferon-gamma. J Immunol 1991;146:1192-7.
12. Schroder JM, Persoon NL, Christophers E. Lipopolysaccharide stimulated human monocytes secrete, apart from neutrophil activating peptide-1/IL-8, a second neutrophil activating protein. NH2 terminal aminoacid sequence identity with melanoma growth stimulatory activity. J Exp Med 1990;171:1091-5.
13. Jinquan T, Vorum H, Larsen CG, et al. Psoriasin: a novel chemotactic protein. J Invest Dermatol 1996;107:5-10.
14. Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, Fitzgerald O. Reduced synovial membrane macrophage number, ELAM-1 expression and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 1993;7:893-900.
15. Kingsley G, Pizsalis C, Kyriazis N, Panayi GS. Abnormal helper-inducer/suppressor-inducer T-cell distribution and T cell activation status are common to all types of chronic synovitis. Scand J Immunol 1988;28:225-32.
16. Espinoza LR, Aguilar GL, Espinoza CG, Cuellar ML, Scopelitis E, Silveira LH. Fibroblast function in psoriatic arthritis. I. Alteration of cell kinetics and growth factor responses. J Rheumatol 1994;21:1502-6.
17. Ellis CN, Gorsulowsky DC, Hamilton TA, et al. Cyclosporin improves psoriasis in double blind study. JAMA 1986;256:3110-6.
18. Griffiths CEM, Powels AV, Leonard JN, Fry L, Baker BS, Valdimarsson H. Clearance of psoriasis with low-dose cyclosporin. BMJ 1986;293:731-2.
19. Finzi AF, Mozzanica N, Cattaneo A, Chiappino G, Pigatto PD. Effectiveness of cyclosporin treatment in severe psoriasis. A clinical and immunological study. J Am Acad Dermatol 1989;21:91-7.
20. Ellis CN, Fradin MS, Messana JM, et al. Cyclosporin for plaque type psoriasis results of a multidose double blind trial. N Engl J Med 1991;324:277-84.
21. Steinsson K, Jonsdottir I, Valdimarsson H. Cyclosporin in psoriatic arthritis: an open study. Ann Rheum Dis 1990;49:603-6.
22. Gupta AK, Matteson EL, Ellis CN, et al. Cyclosporin in the treatment of psoriatic arthritis. Arch Dermatol 1989;125:507-10.
23. Salvarani C, Macchioni P, Boiardi L, et al. Low dose cyclosporin in psoriatic arthritis: Relation between soluble interleukin-2 receptor and response to therapy. J Rheumatol 1992;19:74-9.
24. Rao A. NFATp a cyclosporin-sensitive transcription factor implicated in cytokine gene induction. J Leukocyte Biol 1995;57:536-42.
25. Ho S, Clipstone N, Timmerman L, et al. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 1996;80:S40-5.
26. Moll JMH, Wright W. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55-78.
27. Federicksson T, Petterson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
28. Larsen A, Dale K, Eck M, Pahle J. Radiographic evaluation of rheumatoid arthritis by standard reference films. J Hand Surg 1983;8:667-9.
29. Boiardi L, Salvarani C, Macchioni P, et al. Immunologic effects in patients with psoriatic arthritis treated with cyclosporin A. J Rheumatol 1992;19:1933-7.
30. Nelson PJ, Kim HT, Manning WC, Goralski TJ, Krensky AM. Genomic organisation and transcriptional regulation of the RANTES chemokine gene. J Immunol 1993;151:2601-4.
31. Loetscher P, Dewald B, Baggiolini M, Seitz M. Monocyte chemoattractant protein-1 and interleukin-8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs. Cytokines 1994;6:162-70.
32. Villiger PM, Terkeltaub R, Lotz M. Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol 1992;149:722-7.
33. De Marco D, Kunkel SL, Stricter RM, Basha M, Zurier RB. Interleukin-1 induced gene expression of neutrophil activating protein (IL-8) and monocyte chemotactic peptide in human synovial cells. Biochem Biophys Res Commun 1991;174:411-20.
34. Akahoshi T, Wada C, Endo H, et al. Expression of monocyte chemotactic and activating factor in rheumatoid arthritis. Regulation of its production in synovial cells by interleukin-1 and tumor necrosis factor. Arthritis Rheum 1993;36:762-71.
35. Bedard PA, Golz EE. Cytokines induced expression of mRNAs for chemotactic factors in human synovial cells and fibroblasts. J Cell Physiol 1993;154:433-41.
36. Hachicha M, Rathanaswami P, Schall TJ, McColl S. Production of monocyte chemotactic protein-1 in human type B synoviocytes. Synergistic effect of tumor necrosis factor and interferon-gamma. Arthritis Rheum 1993;36:26-34.
37. Hogan M, Sherry B, Ritchlin C, et al. Differential expression of the small inducible cytokines GRO-alpha and GRO-beta by synovial fibroblasts in chronic arthritis: Possible role in growth regulation. Cytokines 1994;6:61-9.
38. Rathanaswami P, Hachicha M, Sadick M, Shall TJ, McColl S. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem 1993;268:5834-9.
39. Hosaka S, Akahoshi T, Wada C, Kondo H. Expression of the chemokine superfamily in rheumatoid arthritis. Clin Exp Immunol 1994;97:451-7.
40. Koch AE, Kunkel SL, Burrows JC, et al. Synovial tissue macrophage as a source of chemotactic cytokine IL-8. J Clin Invest 1991;147:2187-95.
41. Koch AE, Kunkel SL, Shah MR, et al. Growth related gene product alpha: A chemotactic cytokine for neutrophils in rheumatoid arthritis. J Immunol 1995;155:3660-6.
42. Koch AE, Kunkel SL, Harlow LA, et al. Enhanced production of monocyte chemoattractant protein 1 in rheumatoid arthritis. J Clin Invest 1992;90:772-9.
43. Koch AE, Kunkel SL, Harlow LA, et al. Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophage in rheumatoid arthritis. J Clin Invest 1994;93:921-8.
44. Kojima T, Cromie MA, Fisher GJ, Voorheers JJ, Elder JT. GRO-alpha mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes. J Invest Dermatol 1993;101:767-72.
45. Bacon KB, Premack BA, Gardner P, Schall TJ. Activation of dual T cell signalling pathways by the chemokine RANTES. Science 1995;269:1727-30.
46. Taub DD, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ. Chemokines and T lymphocyte activation 1 Beta chemokines costimulate human T lymphocyte activation in vitro. J Immunol 1996;156:2095-103.